Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1990 Oct;86(4):1306–1312. doi: 10.1172/JCI114839

Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects.

D C Rubinsztein 1, J C Cohen 1, G M Berger 1, D R van der Westhuyzen 1, G A Coetzee 1, W Gevers 1
PMCID: PMC296863  PMID: 2212015

Abstract

The retinyl palmitate fat tolerance test was used to measure chylomicron remnant clearance in 10 normal subjects (apolipoprotein E [apo E] isotypes 3 or 4 only), 6 normolipidemic apo E2/2 homozygotes and 5 familial hypercholesterolemic homozygotes. Skin fibroblasts with fully upregulated LDL receptors from the latter subjects degraded rabbit 125I-beta VLDL in vitro at rates ranging from less than 10-48% of normal. Experiments in vivo revealed no significant differences between the normal and homozygous familial hypercholesterolemic (FHH) subjects in chylomicron remnant clearance assessed on the basis of "areas under the curves" for retinyl palmitate levels present in post-prandial serum, chylomicron remnants (Sf. less than 1,000), or chylomicrons (Sf. greater than 1,000). Remnant clearance was greatly decreased at all times in the apo E2/2 homozygotes, indicative of an important degree of flux control exerted by a receptor-mediated step involving apo E as ligand. The absence of any excess remnant accumulation in FHH subjects with varying "impairment" of LDL receptor-mediated degradation of apo E-containing lipoproteins, permits the conclusion that chylomicron remnants are initially cleared from the plasma by apo E-recognizing receptors which are genetically distinct from LDL receptors.

Full text

PDF
1306

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbeeny C. M., Rifici V. A. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver. J Biol Chem. 1984 Aug 10;259(15):9662–9666. [PubMed] [Google Scholar]
  2. Armstrong V. W., Niedmann D., Eisenhauer T., Janning G., Wagner H., Schuff-Werner P., Seidel D. Acute and long-term effects of low-density lipoprotein apheresis on the serum concentrations of vitamins E and A. Klin Wochenschr. 1988 Feb 1;66(3):123–128. doi: 10.1007/BF01774226. [DOI] [PubMed] [Google Scholar]
  3. Aulinskas T. H., Van der Westhuyzen D. R., Coetzee G. A. Ascorbate increases the number of low density lipoprotein receptors in cultured arterial smooth muscle cells. Atherosclerosis. 1983 May;47(2):159–171. doi: 10.1016/0021-9150(83)90152-1. [DOI] [PubMed] [Google Scholar]
  4. Berr F., Kern F., Jr Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects. J Lipid Res. 1984 Aug;25(8):805–812. [PubMed] [Google Scholar]
  5. Bierman E. L., Stein O., Stein Y. Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res. 1974 Jul;35(1):136–150. doi: 10.1161/01.res.35.1.136. [DOI] [PubMed] [Google Scholar]
  6. Brown M. S., Goldstein J. L. Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic. J Clin Invest. 1983 Sep;72(3):743–747. doi: 10.1172/JCI111044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen J. C. Chylomicron triglyceride clearance: comparison of three assessment methods. Am J Clin Nutr. 1989 Feb;49(2):306–313. doi: 10.1093/ajcn/49.2.306. [DOI] [PubMed] [Google Scholar]
  8. Cooper A. D., Erickson S. K., Nutik R., Shrewsbury M. A. Characterization of chylomicron remnant binding to rat liver membranes. J Lipid Res. 1982 Jan;23(1):42–52. [PubMed] [Google Scholar]
  9. Cortner J. A., Coates P. M., Le N. A., Cryer D. R., Ragni M. C., Faulkner A., Langer T. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects. J Lipid Res. 1987 Feb;28(2):195–206. [PubMed] [Google Scholar]
  10. Fourie A. M., Coetzee G. A., Gevers W., van der Westhuyzen D. R. Two mutant low-density-lipoprotein receptors in Afrikaners slowly processed to surface forms exhibiting rapid degradation or functional heterogeneity. Biochem J. 1988 Oct 15;255(2):411–415. doi: 10.1042/bj2550411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Francke U., Brown M. S., Goldstein J. L. Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease. Proc Natl Acad Sci U S A. 1984 May;81(9):2826–2830. doi: 10.1073/pnas.81.9.2826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goodman D. S., Blomstrand R., Werner B., Huang H. S., Shiratori T. The intestinal absorption and metabolism of vitamin A and beta-carotene in man. J Clin Invest. 1966 Oct;45(10):1615–1623. doi: 10.1172/JCI105468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goodman D. S. Vitamin A metabolism. Fed Proc. 1980 Aug;39(10):2716–2722. [PubMed] [Google Scholar]
  14. Grundy S. M., Mok H. Y. Chylomicron clearance in normal and hyperlipidemic man. Metabolism. 1976 Nov;25(11):1225–1239. doi: 10.1016/s0026-0495(76)80006-6. [DOI] [PubMed] [Google Scholar]
  15. HUANG H. S., GOODMAN D. S. VITAMIN A AND CAROTENOIDS. I. INTESTINAL ABSORPTION AND METABOLISM OF 14C-LABELLED VITAMIN A ALCOHOL AND BETA-CAROTENE IN THE RAT. J Biol Chem. 1965 Jul;240:2839–2844. [PubMed] [Google Scholar]
  16. Hazzard W. R., Bierman E. L. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia). Metabolism. 1976 Jul;25(7):777–801. doi: 10.1016/0026-0495(76)90149-9. [DOI] [PubMed] [Google Scholar]
  17. Hobbs H. H., Brown M. S., Goldstein J. L., Russell D. W. Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hypercholesterolemia. J Biol Chem. 1986 Oct 5;261(28):13114–13120. [PubMed] [Google Scholar]
  18. Hui D. Y., Innerarity T. L., Milne R. W., Marcel Y. L., Mahley R. W. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem. 1984 Dec 25;259(24):15060–15068. [PubMed] [Google Scholar]
  19. Kita T., Goldstein J. L., Brown M. S., Watanabe Y., Hornick C. A., Havel R. J. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3623–3627. doi: 10.1073/pnas.79.11.3623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kovanen P. T., Brown M. S., Basu S. K., Bilheimer D. W., Goldstein J. L. Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1396–1400. doi: 10.1073/pnas.78.3.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Leitersdorf E., Van der Westhuyzen D. R., Coetzee G. A., Hobbs H. H. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest. 1989 Sep;84(3):954–961. doi: 10.1172/JCI114258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mahley R. W., Innerarity T. L. Lipoprotein receptors and cholesterol homeostasis. Biochim Biophys Acta. 1983 May 24;737(2):197–222. doi: 10.1016/0304-4157(83)90001-1. [DOI] [PubMed] [Google Scholar]
  23. Meng M. S., Gregg R. E., Schaefer E. J., Hoeg J. M., Brewer H. B., Jr Presence of two forms of apolipoprotein B in patients with dyslipoproteinemia. J Lipid Res. 1983 Jul;24(7):803–809. [PubMed] [Google Scholar]
  24. Nagata Y., Chen J., Cooper A. D. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver. J Biol Chem. 1988 Oct 15;263(29):15151–15158. [PubMed] [Google Scholar]
  25. Patsch W., Ostlund R., Kuisk I., Levy R., Schonfeld G. Characterization of lipoprotein in a kindred with familial hypercholesterolemia. J Lipid Res. 1982 Nov;23(8):1196–1205. [PubMed] [Google Scholar]
  26. Sherrill B. C., Innerarity T. L., Mahley R. W. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. J Biol Chem. 1980 Mar 10;255(5):1804–1807. [PubMed] [Google Scholar]
  27. Stalenhoef A. F., Malloy M. J., Kane J. P., Havel R. J. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1839–1843. doi: 10.1073/pnas.81.6.1839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tall A., Sammett D., Granot E. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest. 1986 Apr;77(4):1163–1172. doi: 10.1172/JCI112417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weintraub M. S., Eisenberg S., Breslow J. L. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest. 1987 Dec;80(6):1571–1577. doi: 10.1172/JCI113243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Weintraub M. S., Eisenberg S., Breslow J. L. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest. 1987 Apr;79(4):1110–1119. doi: 10.1172/JCI112926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Wernette-Hammond M. E., Garcia Z., Arnold K. S., Innerarity T. L. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1989 Jul-Aug;9(4):501–510. doi: 10.1161/01.atv.9.4.501. [DOI] [PubMed] [Google Scholar]
  32. Wilson D. E., Chan I. F., Ball M. Plasma lipoprotein retinoids after vitamin A feeding in normal man: minimal appearance of retinyl esters among low-density lipoproteins. Metabolism. 1983 May;32(5):514–517. doi: 10.1016/0026-0495(83)90016-1. [DOI] [PubMed] [Google Scholar]
  33. Windler E. E., Greeve J., Daerr W. H., Greten H. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal. Biochem J. 1988 Jun 1;252(2):553–561. doi: 10.1042/bj2520553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Windler E., Chao Y., Havel R. J. Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J Biol Chem. 1980 Jun 10;255(11):5475–5480. [PubMed] [Google Scholar]
  35. Zilversmit D. B., Morton R. E., Hughes L. B., Thompson K. H. Exchange of retinyl and cholesteryl esters between lipoproteins of rabbit plasma. Biochim Biophys Acta. 1982 Jul 20;712(1):88–93. doi: 10.1016/0005-2760(82)90088-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES